Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2021-08-10 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide ....
Regulatory Filings
2021-08-10 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in compliance with Ministry of Corporate Affairs Circular No. 20/2020 dated ....
Regulatory Filings
2021-08-09 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from Link Intime India ....
Regulatory Filings Classification · 100% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificates. It is addressed to the stock exchange and provides details about lost share certificates reported by the registrar and transfer agent. The document is a regulatory announcement informing the exchange and public about a specific event related to share certificates. It does not contain financial statements, management discussion, voting results, or other report content. It is a regulatory filing notifying about a corporate event under SEBI regulations, fitting the category of Regulatory Filings (RNS). The document length is short (1976 characters), and it is not an announcement of a report publication but a direct regulatory notice.
2021-08-08 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received an intimation from its Registrar and ....
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to the stock exchange (BSE Limited) regarding the issuance of a duplicate share certificate to a shareholder. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is an intimation or notification about a specific corporate action related to share certificates, not a financial report, management change, or other detailed filings. The document length is only 1777 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-08-06 English
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board of Directors of the Company is scheduled ....
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2021. It also includes information about the closure of the trading window in compliance with SEBI regulations. The document is short (2611 characters) and serves as an announcement of the upcoming board meeting and trading window closure, not the financial results report itself. It does not contain actual financial data or detailed financial analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-08-06 English
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Regulatory Filings Classification · 95% confidence The document is a notice from the company to the stock exchange about an upcoming Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2021. It also includes information about the closure of the trading window in compliance with SEBI regulations. The document is short (2611 characters) and serves as an announcement of the meeting and trading window closure, not the financial results themselves. It does not contain any financial data or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance notices that do not fit other categories.
2021-08-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.